Logo image of HIPO

HIPPO HOLDINGS INC (HIPO) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:HIPO - US4335392027 - Common Stock

29.71 USD
-0.37 (-1.23%)
Last: 1/2/2026, 1:12:46 PM
Fundamental Rating

4

Taking everything into account, HIPO scores 4 out of 10 in our fundamental rating. HIPO was compared to 148 industry peers in the Insurance industry. The financial health of HIPO is average, but there are quite some concerns on its profitability. HIPO is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

HIPO had positive earnings in the past year.
In the past year HIPO has reported a negative cash flow from operations.
HIPO had negative earnings in each of the past 5 years.
In the past 5 years HIPO reported 4 times negative operating cash flow.
HIPO Yearly Net Income VS EBIT VS OCF VS FCFHIPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

With an excellent Return On Assets value of 5.12%, HIPO belongs to the best of the industry, outperforming 82.43% of the companies in the same industry.
HIPO has a Return On Equity of 22.75%. This is amongst the best in the industry. HIPO outperforms 89.86% of its industry peers.
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROIC N/A
ROA(3y)-13.93%
ROA(5y)-15.77%
ROE(3y)-46.66%
ROE(5y)-56.13%
ROIC(3y)N/A
ROIC(5y)N/A
HIPO Yearly ROA, ROE, ROICHIPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

HIPO has a better Profit Margin (21.31%) than 89.19% of its industry peers.
The Operating Margin and Gross Margin are not available for HIPO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 21.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIPO Yearly Profit, Operating, Gross MarginsHIPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

5

2. Health

2.1 Basic Checks

HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
HIPO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HIPO has more shares outstanding
There is no outstanding debt for HIPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIPO Yearly Shares OutstandingHIPO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HIPO Yearly Total Debt VS Total AssetsHIPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.36, we must say that HIPO is in the distress zone and has some risk of bankruptcy.
HIPO's Altman-Z score of -0.36 is fine compared to the rest of the industry. HIPO outperforms 66.22% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that HIPO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.11, HIPO is in the better half of the industry, outperforming 76.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.36
ROIC/WACCN/A
WACC8.82%
HIPO Yearly LT Debt VS Equity VS FCFHIPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.79 indicates that HIPO has no problem at all paying its short term obligations.
HIPO has a better Current ratio (3.79) than 93.92% of its industry peers.
HIPO has a Quick Ratio of 3.79. This indicates that HIPO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.79, HIPO belongs to the top of the industry, outperforming 93.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
HIPO Yearly Current Assets VS Current LiabilitesHIPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

HIPO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 165.70%, which is quite impressive.
HIPO shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.48%.
Measured over the past years, HIPO shows a very strong growth in Revenue. The Revenue has been growing by 60.72% on average per year.
EPS 1Y (TTM)165.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%662.69%
Revenue 1Y (TTM)34.48%
Revenue growth 3Y59.79%
Revenue growth 5Y60.72%
Sales Q2Q%26.28%

3.2 Future

The Earnings Per Share is expected to grow by 44.34% on average over the next years. This is a very strong growth
HIPO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.11% yearly.
EPS Next Y203.31%
EPS Next 2Y41.48%
EPS Next 3Y32.25%
EPS Next 5Y44.34%
Revenue Next Year27.75%
Revenue Next 2Y22.71%
Revenue Next 3Y21.28%
Revenue Next 5Y19.11%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HIPO Yearly Revenue VS EstimatesHIPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
HIPO Yearly EPS VS EstimatesHIPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10

4

4. Valuation

4.1 Price/Earnings Ratio

HIPO is valuated reasonably with a Price/Earnings ratio of 8.21.
Based on the Price/Earnings ratio, HIPO is valued a bit cheaper than 72.97% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.51, HIPO is valued rather cheaply.
The Price/Forward Earnings ratio is 8746.98, which means the current valuation is very expensive for HIPO.
82.43% of the companies in the same industry are cheaper than HIPO, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of HIPO to the average of the S&P500 Index (23.13), we can say HIPO is valued expensively.
Industry RankSector Rank
PE 8.21
Fwd PE 8746.98
HIPO Price Earnings VS Forward Price EarningsHIPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 2K 4K 6K 8K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HIPO Per share dataHIPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

HIPO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HIPO's earnings are expected to grow with 32.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y41.48%
EPS Next 3Y32.25%

0

5. Dividend

5.1 Amount

HIPO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HIPPO HOLDINGS INC

NYSE:HIPO (1/2/2026, 1:12:46 PM)

29.71

-0.37 (-1.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-04 2026-03-04/amc
Inst Owners49.97%
Inst Owner Change-6.11%
Ins Owners9.1%
Ins Owner Change-5.29%
Market Cap752.85M
Revenue(TTM)450.10M
Net Income(TTM)95.90M
Analysts80
Price Target40.46 (36.18%)
Short Float %2.42%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.4%
Min EPS beat(2)89.54%
Max EPS beat(2)107.26%
EPS beat(4)3
Avg EPS beat(4)215.38%
Min EPS beat(4)-18.4%
Max EPS beat(4)683.12%
EPS beat(8)6
Avg EPS beat(8)113.05%
EPS beat(12)7
Avg EPS beat(12)69.89%
EPS beat(16)7
Avg EPS beat(16)40.05%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)1.08%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)3.95%
Revenue beat(12)8
Avg Revenue beat(12)4.79%
Revenue beat(16)9
Avg Revenue beat(16)3.48%
PT rev (1m)-1.65%
PT rev (3m)7.21%
EPS NQ rev (1m)20%
EPS NQ rev (3m)277.78%
EPS NY rev (1m)328.48%
EPS NY rev (3m)95.34%
Revenue NQ rev (1m)-0.91%
Revenue NQ rev (3m)-0.16%
Revenue NY rev (1m)0.76%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 8.21
Fwd PE 8746.98
P/S 1.67
P/FCF N/A
P/OCF N/A
P/B 1.79
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)3.62
EY12.18%
EPS(NY)0
Fwd EY0.01%
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS17.76
BVpS16.63
TBVpS14.37
PEG (NY)0.04
PEG (5Y)N/A
Graham Number36.81
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.31%
GM N/A
FCFM N/A
ROA(3y)-13.93%
ROA(5y)-15.77%
ROE(3y)-46.66%
ROE(5y)-56.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.28%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z -0.36
F-Score6
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)139.06%
Cap/Depr(5y)143.13%
Cap/Sales(3y)13.98%
Cap/Sales(5y)15.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)165.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%662.69%
EPS Next Y203.31%
EPS Next 2Y41.48%
EPS Next 3Y32.25%
EPS Next 5Y44.34%
Revenue 1Y (TTM)34.48%
Revenue growth 3Y59.79%
Revenue growth 5Y60.72%
Sales Q2Q%26.28%
Revenue Next Year27.75%
Revenue Next 2Y22.71%
Revenue Next 3Y21.28%
Revenue Next 5Y19.11%
EBIT growth 1Y72.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.62%
EBIT Next 3Y33.9%
EBIT Next 5Y28.14%
FCF growth 1Y90.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.46%
OCF growth 3YN/A
OCF growth 5YN/A

HIPPO HOLDINGS INC / HIPO FAQ

What is the fundamental rating for HIPO stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIPO.


What is the valuation status for HIPO stock?

ChartMill assigns a valuation rating of 4 / 10 to HIPPO HOLDINGS INC (HIPO). This can be considered as Fairly Valued.


Can you provide the profitability details for HIPPO HOLDINGS INC?

HIPPO HOLDINGS INC (HIPO) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for HIPO stock?

The Earnings per Share (EPS) of HIPPO HOLDINGS INC (HIPO) is expected to grow by 203.31% in the next year.